It includes the 2c-xs, NBOMEs, DOXs, stimulants like 2-fa/4-fma/a-PVP, the JWH series and other synthetic cannabinoids, Methoxetamine, tryptatmines such as aMT and 5-meo-dmt, and fentanyl based compounds. Full list : http://pastebin.com/VsSBdLv3 Some noteable absences are lysergic compounds and 4-subbed tryptamines. It's by no means exhaustive but it's big enough to mean that there will be an adjustment period on the market.
Sad news. I guess this means we may be seeing a whole new wave of previously un-tested chemicals rolling through the scene.